Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Exascale Labs › ARC Group International Limited now owns 14.7% of XLAB as a passive in Fund moves
Why it stands out A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Oct 7, 2026
Reporting period Not applicable
Filed with the SEC Oct 15, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001493152-26-047255
Data quality Verified: identifiers matched exactly
Around the same time Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Insider filing
Traded Oct 6 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 6 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 27, 2026 Company filing · Form 8-K · Material agreement, Agreement ended Completed buying or selling a business or assets, and received a notice from its stock exchange (and 9 more items) “The information set forth in the Introductory Note of this Current Report on Form 8-K and in the section entitled “Information about Directors and Executive Officers” in Item 2.01 of this Current Report on Form 8-K is incorporated by reference herein.” Aug 27, 2026 Company filing · Form 8-K · Acquisition or sale Completed buying or selling a business or assets “The disclosures set forth in (i) the “ Introductory Note ” above and (ii) the “ Introductory Note ” and Item 1.01 of the Original Form 8-K are incorporated into this Item 2.01 by reference. 1 FORM 10 INFORMATION Item 2.01(f) of Form 8-K states that if the predecessor registrant was a shell company, as BCAR was immediately before the consummation of the Business Combination, then the registrant must disclose the…” Sep 4, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On September 4, 2026, Exascale Labs Holdings Inc. (the “Company”) appointed Gildas Bonnier as Interim Chief Financial Officer of the Company, effective as of September 4, 2026.” Sep 25, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “Effective September 25, 2026, Gildas Bonnier ceased serving as the Interim Chief Financial Officer of Exascale Labs Holdings Inc. (the “Company”). As previously reported, Mr. Bonnier was appointed as the Company’s Interim Chief Financial Officer while the Company conducted a formal search process to identify and appoint a permanent Chief Financial Officer of the Company.” Sep 28, 2026 Company filing · Form 8-K · Results Reported its results What came next Oct 9, 2026 Company filing · Form 8-K · Material agreement Signed an important agreement Oct 15, 2026 5% stake ARC Group International Limited reported a passive stake (13G) of 14.7% Oct 29, 2026 5% stake Hack Seed Fund II LP reported a passive stake (13G) of 5.9% Nov 3, 2026